BBNA
NAGE

Bremer Bank National Association’s Niagen Bioscience NAGE Stock Holding History

Bremer Bank National Association’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,816
Closed -$13K – 680
2019
Q1 		$13K Buy
+2,816
New +$10.2K ﹤0.01% 637

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bremer Bank National Association's NAGE Position: Q2 2019 in Review

Bremer Bank National Association sold out of Niagen Bioscience (NAGE) in Q2 2019, closing a stake of 2,816 shares — an estimated $13K sold.

Bremer Bank National Association first reported a position in NAGE in Q1 2019 and held it in 1 quarter. The position peaked at $13K in Q1 2019. 58 funds tracked by Wall St. Rank hold NAGE as of Q2 2019.

  • Bremer Bank National Association reported no remaining Niagen Bioscience position as of Q2 2019 after selling out during the quarter.
  • Bremer Bank National Association sold 2,816 Niagen Bioscience shares in Q2 2019, an estimated $13K.
  • Bremer Bank National Association first reported a position in Niagen Bioscience in Q1 2019 and held it in 1 quarter.
  • Bremer Bank National Association's Niagen Bioscience position peaked at $13K in Q1 2019.
  • 58 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2019.

Based on Bremer Bank National Association's 13F filing for Q2 2019, filed 13 Aug 2019.